Elderly breast cancer patients risk treatment discrimination

September 22, 2011, ECCO-the European CanCer Organisation

Stockholm, Sweden: Women diagnosed with breast cancer late in life are at greater risk of dying from the disease than younger patients, assuming they survive other age-related conditions, according to a study to be presented at the 2011 European Multidisciplinary Cancer Congress on Saturday. The results point to shortcomings in patient care for elderly women as well as differences in the progress of the disease.

Researchers led by Professor Christos Markopoulos from Athens University Medical School (Athens, Greece) used the population of the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial to examine competing causes of death in post-menopausal women with early breast cancer. Participants were treated with exemestane for five years or tamoxifen for 2.5 years followed by for 2.5 years. This use of the data was possible because, after five years, the trial had found no difference in outcomes between the two treatments it was comparing.

The 9,766 patients were classified by their age at diagnosis, separating those below 65 years of age, those between 65 and 75, and those above 75. All patients had positive tumours, 50% had node negative disease, 68% received radiotherapy, and 36% received chemotherapy.

An analysis of their progress over the 5.1 years of the trial found that although the risk of dying from causes other than breast cancer was much higher in elderly patients, the risk of dying of breast cancer also increased with age.

Applying a that takes into account the risk of competing causes of death in the , it was found that the risk of dying from breast cancer was indeed greater for those diagnosed later in age.

According to Prof. Markopoulos, who is also Chair of the Hellenic Society of Breast Surgeons, the higher absolute death rate amongst with breast cancer suggests they are not receiving standard treatment. "Our findings show that elderly breast cancer patients are more likely to die from something else other than from breast cancer – for instance, age specific co-morbidities such as heart attack. However, for those not suffering from other conditions or those who have survived other conditions, deaths from breast cancer are higher compared to younger patients with the same tumour characteristics," he explains. "This probably means that old women with breast cancer are being under-treated as doctors think they will die from something else."

Several factors which can cause breast cancer mortality with increasing age, such as an age specific decrease in the function of the immune system on tumour progression, could potentially affect the results but cannot be easily assessed, says Prof. Markopoulos. "However, we observed that radiotherapy was administered less frequently and administration of chemotherapy sharply decreased with increasing age. Thus, it is most likely that under-treatment of the elderly may explain the worse age-specific breast cancer outcome found in our study," he says.

Underlying this situation is a false perception that the outlook for older women with breast cancer is relatively good, says Prof. Markopoulos. "This false impression is most likely due to deaths from other age-related conditions."

He goes on to say: "Several other studies have shown that elderly have lower odds of receiving standard care, including deviations from guidelines for surgery, radiotherapy and chemotherapy. More work should be done to clarify the picture in the elderly population, as patients of this age group are usually excluded from major clinical trials."

ECCO president, Professor Michael Baumann, said, "Elderly patients have often been considered as being not fit for state-of-the-art cancer care. A host of recent studies have shown that it is not age per se, but rather the status of health that are important parameters for predicting how well an individual may tolerate treatments. All over Europe we see an increase in numbers of elderly patients and we more often see elderly patients who are fit and very good candidates for standard cancer treatments. Educational efforts, but also detailed research on predictors and supportive measures, are key to make sure that all cancer patients, irrespective of age, receive evidence based, best individual treatment approaches."

Commenting on the study, which he was not involved in, Dr. Etienne Brain from Hôpital René Huguenin of the Institut Curie, France, stressed that evaluating competing risks remained a key issue in older patients with cancer, although it could yield opposite conclusions according to tumour type. "It relies mostly on the assessment of comorbidities and functional status, two items that the Société Internationale d'Oncologie Gériatrique (SIOG) has been strongly advocating to consider for almost ten years when taking decisions about treatment for elderly cancer patients, and which might help to estimate individual life expectancy," he said.

"Although this study confirms that causes not related to breast cancer are the main reasons for death, it also suggests the likelihood that the diverse nature of the hormone-positive disease plays a role too. We need to improve the prognostic classification in the elderly, developing specific tools or implementing those developed for younger , in order not to deprive those who might derive a real benefit from additional treatment including chemotherapy."

Dr. James Bellini, a leading futures analyst and broadcaster who will give the keynote lecture at the opening ceremony for the 2011 European Multidisciplinary Cancer Congress on Friday evening, will urge policymakers to prepare for demographic challenges of the kind highlighted by Prof. Markopoulos's study. "An ageing Europe with falling populations and major financial problems will pose a growing challenge for healthcare policies. Not only will conditions like cancer and diabetes rise sharply, but Europe will face an enormous and growing need for care – both short and long term," he will say. "If the future care challenge is not to become a crisis we need a new kind of 'capitalism' built around purpose and not simply around economic gain. Human communities must be at the heart of this endeavour."

Explore further: Heart disease beats breast cancer as the biggest killer

Related Stories

Heart disease beats breast cancer as the biggest killer

June 19, 2011
Breast cancer accounts for almost a third of all cancer cases reported in women. However advances in the treatment for breast cancer, and early detection, have improved the chances of survival from the disease. New research ...

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.